Metraipolis › archive › dc_de8000346f99

Alliance for clinical trials in Oncology (Alliance) trial A022101/NRG-GI009: a pragmatic randomized phase III trial evaluating total ablative therapy for… — Europe PMC PMID:38350888

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/38350888
DOI
10.1186/s12885-[numero omesso]-2
License (as archived)
solo-consultazione
Archived
2026-11-01T07:04:38.483Z
SHA-256 of the archived text
ea3d0422f034d6458c6edb896a977787cf791d58fedb496af0173da4b361dae5
Stable URL of this page
https://metraipolis.com/documento/dc_de8000346f99

How to cite

Alliance for clinical trials in Oncology (Alliance) trial A022101/NRG-GI009: a pragmatic randomized phase III trial evaluating total ablative therapy for… — Europe PMC PMID:38350888 — Europe PMC (en), https://europepmc.org/article/MED/38350888 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_de8000346f99 (Metraipolis archive dc_de8000346f99, sha256 ea3d0422f034d6458c6edb896a977787cf791d58fedb496af0173da4b361dae5)
BibTeX
@misc{dcde8000346f99,
  title = {Alliance for clinical trials in Oncology (Alliance) trial A022101/NRG-GI009: a pragmatic randomized phase III trial evaluating total ablative therapy for… — Europe PMC PMID:38350888},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/38350888},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_de8000346f99; sha256 ea3d0422f034d6458c6edb896a977787cf791d58fedb496af0173da4b361dae5},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/38350888. Agents can read the archived copy with the MCP tool read_document.